Six recipients of the Pershing Square Sohn Prize for Young Investigators participated in this year’s Forum at the Alexandria Center for Life Science in New York City. The event featured talks by leaders in the pharmaceutical and medical industries. Following the Forum, special guests, board members and prize winners attended the Prix Galien Awards Ceremony at the American Museum of Natural History.
On Wednesday, May 25th, the Pershing Square Research Alliance held its third annual dinner at the Park Avenue Armory, awarding its 2016 Prize in Cancer Research to seven exceptional innovative scientists in New York City.
On Wednesday, May 25th, the Pershing Square Research Alliance held its third annual dinner at the Park Avenue Armory, awarding its 2016 Prize in Cancer Research to seven exceptional innovative scientists in New York City.
On Thursday, May 7th, the Pershing Square Research Alliance held its second annual dinner at the Park Avenue Armory, awarding its 2015 Prize in Cancer Research to six exceptional innovative scientists in New York City.
On Thursday, May 7th, the Pershing Square Research Alliance held its second annual dinner at the Park Avenue Armory, awarding its 2015 Prize in Cancer Research to six exceptional innovative scientists in New York City.
The Pershing Square Sohn Cancer Research Alliance recently sponsored a panel entitled, “Pioneers for a Cure: the Role of Innovation and Entrepreneurship in Cancer Research” at the 5th Annual Galien Forum.
Through a generous commitment of $25 million from the Pershing Square Foundation, the Pershing Square Sohn Cancer Research Alliance has created a prestigious program that will award $1.2 million in its first year to exceptional young scientists in New York City with innovative ideas in the field of cancer research.
The Pershing Square Sohn Cancer Research Alliance celebrated its inaugural dinner and awarding the Pershing Square Sohn Prize to six young, innovative scientists in New York City for cancer research.
The Pershing Square Sohn Prize for Young Investigators in Cancer Research was announced on October 22 at the annual Galien Forum in New York.